Skip to main content
The American Journal of Tropical Medicine and Hygiene logoLink to The American Journal of Tropical Medicine and Hygiene
. 2016 Jun 1;94(6):1301–1308. doi: 10.4269/ajtmh.15-0746

Molecular Epidemiology of Blood-Borne Human Parasites in a Loa loa-, Mansonella perstans-, and Plasmodium falciparum-Endemic Region of Cameroon

Papa M Drame 1,*, Céline Montavon 1, Sébastien D Pion 1, Joseph Kubofcik 1, Michael P Fay 1, Thomas B Nutman 1
PMCID: PMC4889748  PMID: 27044568

Abstract

The study of the interactions among parasites within their hosts is crucial to the understanding of epidemiology of disease and for the design of effective control strategies. We have conducted an assessment of infections with Loa loa, Mansonella perstans, Wuchereria bancrofti, and Plasmodium falciparum in eastern Cameroon using a highly sensitive and specific quantitative polymerase chain reaction assay using archived dried whole blood spots. The resident population (N = 1,085) was parasitized with M. perstans (76%), L. loa (39%), and P. falciparum (33%), but not with W. bancrofti. Compared with single infections (40.1%), coinfection was more common (48.8%): 21.0% had L. loaM. perstans (Ll+/Mp+/Pf), 2.7% had L. loaP. falciparum (Ll+/Pf+/Mp), 15.1% had M. perstansP. falciparum (Mp+/Pf+/Ll), and 10.0% had L. loaM. perstansP. falciparum (Ll+/Mp+/Pf+). Interestingly, those with all three infections (Ll+/Mp+/Pf+) had significantly higher L. loa microfilaria (mf) counts than either single Ll+ (P = 0.004) or double Ll+/Mp+ (P = 0.024) infected individuals. Of those infected with L. loa, the mean estimated counts of L. loa mf varied based on location and were positively correlated with estimated intensities of M. perstans mf. Finally, at a community level, heavy L. loa infections were concentrated in a few individuals whereby they were likely the major reservoir for infection.

Background

Humans are subject to infection by a variety of parasites (protozoan and metazoan) throughout their life. In tropical regions, multiple parasitic infections are the rule, given their overlapping endemicity.1 Helminth coinfections alone affect over 800 million people and outnumber single (or no) infection in many communities living in low-income, resource-limited parts of the world.26

Although soil-transmitted helminths (hookworms, Ascaris, and Trichuris) represent the greatest proportion of coinfecting species,710 blood-borne infections involving filarial and malarial parasites have been described in many parts of the world. For example, coinfections with Plasmodium spp. and Wuchereria bancrofti, which can be transmitted by the same vectors, have been described in India,11 Guyana,12 Kenya,13 Mali,14 and Tanzania4 among many other countries. Dual infections with Plasmodium spp. and either Loa loa, Mansonella perstans or Mansonella ozzardi, three clinically less-important filarial parasites, have been seen in populations living in Uganda, Cameroon, and Argentina.10,1517 Coinfections involving only filarial helminths are similarly well known: L. loa and M. perstans dual infections have been observed in Cameroon,18 Congo,19 Gabon,20,21 and Nigeria,22 and L. loaOnchocerca volvulus coinfection has been described in Cameroon.23,24 Concomitant infections with three (or more) human filarial helminths have also been reported.25

Coinfecting parasites within hosts have been postulated to compete with each other directly for host resources26 or indirectly through the host immune system.27 Such interactions can alter disease severity, transmission, or infection dynamics. They can then strongly influence the epidemiology of associated diseases.2,28 For example, in central Africa, treatment of O. volvulus (or W. bancrofti) in the presence of L. loa can cause severe posttreatment side effects that can lead to death.23,29 Plasmodium and filarial helminth coinfections have also been described,9,30,31 with contrasting effects on the epidemiology of malaria, making the nature of such interactions not always predictable. Therefore, the knowledge of interactions among parasites is important in understanding the epidemiology of infections and the diseases they cause.

Recent advances in molecular biology have allowed the development of a range of new, relatively cheap, and rapid high-throughput molecular assays. These molecular tools can be used to examine and quantitate parasites (or their DNA) directly from archived clinical or environmental samples, and then to study the dynamics of specific parasitic infections among host populations.32,33 These molecular tools offer insights into our understanding of the transmission, pathogenesis, progression, and control of parasitic diseases in situations of polyparasitism.33 To date, disease control programs mostly adopt a vertical approach to intervention, dealing with each pathogen in isolation. Because pathogen interactions worsen human health and increase transmission potential, control measures need to be more integrated.

The objective of the study was to determine if a molecular epidemiologic approach could help to understand the population biology of important vector-borne parasitic infections in a previously unmapped region of the world, using anonymized, archived samples that would have been discarded. This was a “proof of principle” study to assess the feasibility of using such an approach with an emphasis on L. loa infection in Cameroon, as it has recently gained prominence because of the possible serious adverse events occurring after ivermectin administration. In so doing, we identified epidemiological (demographic and biological) factors that may play a crucial role in the human susceptibility to and the transmission of L. loa.

Methods

Ethics statement.

This study was derived from a cross-sectional epidemiologic study of human immunodeficiency virus (HIV) and syphilis prevalence. This study received ethical clearance from the National Ethics Committee of Cameroon. The objectives of the study were explained orally to all eligible individuals. Written informed consent was obtained from all participants or from an adult parent or guardian for children. This study used anonymized and coded individual samples that were about to be discarded. These were deemed exempted from National Institutes of Health Institutional Review Board approvals by the Office of Human Subjects Research.

Study area.

The study was conducted in the district of Messok (3°05′04.9″N and 14°03′48.9″E), a rural area located in the Haut-Nyong Department, in the eastern region of Cameroon. It is a densely forested area with an annual average rainfall of 2,800 mm, the rainy season lasting from March to November. Average temperatures monthly varied between 22°C and 25°C. This region had not been previously mapped for parasitic infections. All individuals from eight villages—Bareko, Karagoua, Kamelone, Long, Messok, Messea, Nkouakom, and Yanebot—were invited to participate. Messok village was the largest and the focal point village. There had been no mass drug administration programs for control of onchocerciasis, lymphatic filariasis, or soil-transmitted helminths.

Sample collection.

All samples were archived samples that had been acquired as part of a cross-sectional survey for sexually transmitted infections, namely HIV and syphilis, between October and November 2012. As mentioned above, these were coded, anonymized convenience samples from healthy volunteering individuals aged ≥ 2 years. Whole blood had been collected by venipuncture during the day from 10:00 am to 4:00 pm, and 50 μL were spotted onto filter paper (Whatman no. 1 filter paper). Blood spots were then sun/air-dried for 15–20 minutes and stored at room temperature until used for DNA extraction. Each dried blood-spotted filter paper was kept individually in a paper pouch in such a way that samples from each individual were physically separated from one another.

DNA extraction for field-collected blood spot samples.

DNA was extracted from the dried blood spots as previously described.34 In brief, two punched (4 mm each) blood spots were immersed in 400 μL water in a tube containing ceramic beads (Peqlab, Wilmington, DE). These tubes were then homogenized at 6,500 × g for 5 minutes, and then heated for 30 minutes at 99°C while shaking in a thermomixer (Eppendorf North America, New York, NY). Finally, the samples were centrifuged at 15,700 × g for 10 minutes, and the supernatant was collected for use.

Extraction of genomic DNA.

Genomic DNA (used as positive controls) was obtained from microfilariae of L. loa, M. perstans, and W. bancrofti and from P. falciparum parasites using a previously described method.35

Quantitative polymerase chain reaction assays.

Primers and probes for specific amplification of L. loa microfilaria (mf), M. perstans mf, W. bancrofti mf, and P. falciparum (GenBank accession nos. HM753552.1, U31640.1, U31644.1, and NC_004331, respectively) have been described previously3537 and are listed in Supplemental Table 1.

Quantitative polymerase chain reaction (qPCR) assays for detection of genomic DNA of L. loa mf, M. perstans mf, and W. bancrofti mf and P. falciparum were performed on a Viia7 detection system (Life Technologies, Grand Island, NY) using TaqMan Kapa Probe Fast qPCR Kit reagents (Kapa Biosystems Inc., Wilmington, MA) and primer/probe sets described in Supplemental Table 1. All assays were done in a 10-μL reaction mixture consisting of 5 μL of 2 × KAPA (Kapa Biosystems Inc.) buffer, 0.9 ηM of each primer and 0.25 ηM of the corresponding 6-carboxyfluorescein (FAM) probe, 2 μL of extracted DNA (template), and 2.75 μL ultrapure water. Genomic DNAs were used as positive controls, ultrapure water as negative controls (no template controls [NTCs]), and all assays were run in duplicate. Amplification conditions were 20 seconds at 95°C followed by 40 cycles of 1 second at 95°C and 20 seconds at 60°C. The quality of templates was confirmed by testing all samples for the ability to amplify a control plasmid DNA (New England BioLabs Inc., Ipswich, MA) added before DNA extraction to ensure a lack of inhibition.

Assessment of parasitic infections.

A sample was considered positive if the read cycle number (Ct) value was at least two Ct values lower than the mean value of the NTCs (CtNTCs). The estimated number of L. loa mf was obtained by extrapolating from a standard curve derived from blood samples spiked with dilutions of a known count of mf as previously described.35 Mansonella perstans mf, W. bancrofti mf, and P. falciparum parasites were quantified using a relative method based on the following formula: 2−(ΔCt), where ΔCt = Ctx (mean duplicates of sample x) − CtNTCs (mean values of negative controls [water]).

Statistical analyses.

Fisher's exact test was used to compare parasite prevalence between groups (when there were more than two groups, the Fisher's exact test was calculated by simulating with 100,000 replications), and the nonparametric Mann–Whitney (two groups) tests were used to estimate difference in parasite intensities. We used a hurdle method to model L. loa counts. This is a two-part model. The first part is a logistic regression that models L. loa presence or absence and the second part models the positive L. loa counts using a zero-truncated quasi-Poisson model. The regressors were the same for both parts of the model: host age (eight categories), gender, location (eight villages), and log10 intensity (undetectable counts are set to 1, so that their log10 values are 0) of coinfection with M. perstans or P. falciparum. For statistical inferences, we used the Wald method for the logistic model and nonparametric bootstrap method (B = 2,000 replications, percentile confidence intervals) for the truncated quasi-Poisson model. The latter method is used for the truncated model because it is more robust to model misspecification. No tests were done on the village or age effects for the truncated model because it is not straightforward to apply the bootstrap in those cases. The slopes and P values in Figure 1 are linear models within each village. Analyses were done using R software version 3.2.0 and the hurdle models used the pscl R package.38

Figure 1.

Figure 1.

Association between Loa loa and Mansonella perstans infections based on the location of residence. A separate linear model was fit for each village to evaluate the strength of the association between L. loa microfilaria loads and the relative intensities of M. perstans infection in each of the eight villages studied. The slope of the line and the P value of significance are indicated for each village.

Results

A total of 1,170 samples were tested for L. loa, W. bancrofti, and M. perstans and for P. falciparum detection and quantification. Of these, 26 samples were not interpretable because the positive control for DNA extraction (spiked pBR322 plasmid) was unamplifiable. The final data set thus had only N = 1,085 subjects, as an additional 59 subjects had missing gender information, and 58 of those 59 had missing age information as well.

General characteristics.

The resulting studied population (N = 1,085) included 613 women (56.5%) and 472 men (43.5%) with an age distribution shown in Table 1. The gender ratio did not differ by location (P = 0.94) but the age distribution did differ among the villages (P < 0.001).

Table 1.

General characteristics of the studied population

Total population (N = 1,085) Bareko (N = 50) Kamelone (N = 104) Karagoua (N = 119) Long (N = 118) Messea (N = 113) Messok (N = 402) Nkouakom (N = 92) Yanebot (N = 87)
Gender: % (n)
 Male 43.5 (472) 38.0 (19) 41.3 (43) 47.1 (56) 40.7 (48) 42.5 (48) 44.0 (177) 46.7 (43) 43.7 (38)
 Female 56.5 (613) 62.0 (31) 58.7 (61) 52.9 (63) 59.3 (70) 57.5 (65) 56.0 (225) 53.3 (49) 56.3 (49)
Age classes (years): % (n)
 < 15 (N = 90) 8 (90) 4 (2) 8 (9) 4 (4) 17 (70) 6 (5)
 15–19 (N = 151) 14 (151) 6 (3) 8 (8) 11 (13) 7 (8) 17 (19) 19 (75) 14 (13) 14 (12)
 20–29 (N = 247) 23 (247) 18 (9) 17 (18) 34 (40) 29 (34) 26 (29) 16 (63) 32 (29) 29 (25)
 30–39 (N = 196) 18 (195) 20 (10) 22 (23) 28 (33) 19 (22) 12 (14) 15 (62) 21 (19) 14 (12)
 40–49 (N = 152) 14 (152) 18 (9) 22 (23) 9 (11) 19 (22) 13 (15) 10 (42) 12 (11) 22 (19)
 50–59 (N = 99) 9 (99) 10 (5) 12 (12) 6 (7) 9 (11) 11 (12) 10 (39) 9 (8) 6 (5)
 60–69 (N = 62) 6 (62) 2 (1) 10 (10) 2 (2) 8 (9) 4 (5) 6 (25) 9 (8) 2 (2)
 > 69 (N = 89) 8 (89) 22 (11) 10 (10) 3 (4) 10 (12) 13 (15) 6 (26) 4 (4) 8 (7)

Prevalence of parasite species.

In the analyzed population (N = 1,085), the prevalence of infection with M. perstans mf, L. loa mf, and P. falciparum was 75.9%, 38.7%, and 33.3%, respectively. No W. bancrofti infection was detected. The prevalence ranged between 27.6% and 62.0% for L. loa, 64.4% and 89.1% for M. perstans, and 23.1% and 37.0% for P. falciparum (Table 2). For each parasite studied, the prevalence of infection was higher in men compared with women: 80.3% versus 72.4% for M. perstans (P = 0.003), 42.6% versus 35.7% for L. loa (P = 0.02), and 36.9% versus 30.5% for P. falciparum (P = 0.03). We found significant age effects for P. falciparum prevalence (P < 0.001) and M. perstans prevalence (P = 0.003), but not for L. loa mf prevalence (P = 0.97).

Table 2.

Prevalences of species according to location

Villages (effective) Loa loa mf % (n) Mansonella perstans mf % (n) Plasmodium falciparum % (n)
Bareko (N = 50) 62.0 (31) 74.0 (37) 30.0 (15)
Kamelone (N = 104) 32.7 (34) 83.6 (87) 23.1 (24)
Karagoua (N = 119) 50.4 (60) 79.8 (95) 34.4 (41)
Long (N = 118) 28.8 (34) 83.9 (99) 33.1 (39)
Messea (N = 113) 29.2 (33) 81.4 (92) 30.1 (34)
Messok (N = 402) 38.3 (154) 64.4 (259) 35.6 (143)
Nkouakom (N = 92) 54.3 (50) 89.1 (82) 37.0 (34)
Yanebot (N = 87) 27.6 (24) 82.8 (72) 35.6 (31)

mf = microfilaria. Species prevalences are represented as %, and the number of positives is indicated in brackets.

The distribution of infection combinations is shown in Figure 2 . Only 11.1% of individuals were completely uninfected with any of the parasite species tested. Thus, 88.9% had at least one infection: 40.1% had single infections and 48.8% had two or more infections. In detail, 21.0% were L. loa mf–M. perstans mf coinfected, 2.7% were L. loa mf–P. falciparum positive, 15.1% had M. perstans mf–P. falciparum infections, and 10.0% were infected with all three species (Figure 2).

Figure 2.

Figure 2.

Distribution of species prevalences within the host population. The relative frequency of single, double, and triple infections with Loa loa, Mansonella perstans, and/or Plasmodium falciparum are represented for the whole population (black), for men (blue), and for women (dark red). The “+” and “−” signs indicate the presence (+) or absence (−) of the corresponding species.

Factors influencing susceptibility to and intensity of L. loa infection.

Taking L. loa infection as the infection of interest, people with triple infections (Ll+/Mp+/Pf+) had higher estimated L. loa mf counts than either single L. loa (Ll+; P = 0.004) or double L. loaM. perstans (Ll+/Mp+; P = 0.024). The estimated L. loa mf counts in individuals with triple infection were not significantly higher than L. loa mf–P. falciparum (Ll+/Pf+; P = 0.25) infected individuals (Figure 3 ).

Figure 3.

Figure 3.

Level of Loa loa microfilaria (mf) counts according to the infection status. A comparison of the estimated counts of L. loa mf/mL among those with single L. loa (Ll+), double L. loa/Mansonella perstans (Ll+/Mp+) and L. loa/Plasmodium falciparum (Ll+/Pf+), and triple L. loa/M. perstans/P. falciparum (Ll+/Mp+/Pf+) infections.

On the basis of a logistic model of L. loa mf prevalence (part 1 of the hurdle model), village location had a highly significant effect (P < 0.001) but age (P = 0.86) and gender (P = 0.09) played little to no role. The logistic model shows that each log10 increase in M. perstans intensity increases the odds of L. loa presence by a factor of 1.23 (95% confidence interval [CI] = 1.13–1.34; P < 0.001), while there is no analogous change in odds for each log10 increase in P. falciparum intensity (odds ratio [OR] = 0.93, 95% CI = 0.81–1.07, P = 0.30).

On the basis of the quasi-Poisson model, estimated L. loa intensity in males is not significantly different from females (P = 0.94). Estimated L. loa mf density was positively associated with estimated M. perstans mf density, but this association was just at the level of significance (1 log10 increase in M. perstans mf density was associated with a 1.55-fold increase in L. loa mf density; 95% CI = 1.00–4.04, P = 0.051). Estimated P. falciparum intensity had no effect on estimated L. loa mf density (1 log10 increase in P. falciparum density was associated with only a 1.06-fold increase in L. loa mf density; 95% CI = 0.52–2.01, P = 0.80).

Association between L. loa and M. perstans infections based on location.

In Figure 1, we represented the estimated L. loa mf density as a function of estimated M. perstans intensity for each village for those with L. loa infection. We fitted linear models and tested that the slope is different from zero. Although we only see significantly positive slopes (positive association between L. loa and M. perstans densities) in two villages (Nkouakom, P = 0.008 and Yanebot, P = 0.038), all of the eight villages estimate had positive slopes. Thus, this analysis also supports a positive association between L. loa and M. perstans.

Community distribution of L. loa and M. perstans microfilarial densities.

Because estimated L. loa and M. perstans mf loads appeared to be strongly associated, we were interested to see how these two parasites were distributed within the studied communities. A more detailed analysis shows that 0.6% (7/1,085) of people harbored more than 10,000 L. loa mf/mL of blood and contributed to more than 69.7% of the total estimated L. loa mf load in the studied communities and that 2.9% (32/1,085) of the population harbored 90.7% of the estimated community mf loads (Figure 4A and C ). Of note, three individuals (one man and two women) were parasitized with more than 30,000 L. loa mf/mL of blood. In contrast, for M. perstans, it required 183 (16.9% of people) most heavily infected individuals to contribute to 90.2% of the estimated community mf load (Figure 4B and C).

Figure 4.

Figure 4.

Community distribution of Loa loa and Mansonella perstans. (A) The number of individuals with a given range of L. loa or (B) M. perstans are shown. The contribution of each of these ranges to the community microfilarial load (total of community mf) for L. loa mf (C) or M. perstans mf (D) is shown as a percent of the total community mf count.

Discussion

The knowledge of the interactions among parasites within their hosts is crucial to the understanding of transmission, pathogenesis, patterns of disease, and for the design of effective control and elimination strategies.33 This study demonstrates the utility of molecular tools to drive a post hoc epidemiological assessment of the prevalences and intensities of (co)infections/transmission of three blood-borne filarial and one malaria parasites (L. loa, W. bancrofti, M. perstans, and P. falciparum). As L. loa mf infection was our main interest in this study, we highlighted as well the epidemiological factors associated with variations of the intensity of L. loa mf infection, and likely the transmission of loiasis.

Populations residing in this region of east Cameroon appear to be highly parasitized with M. perstans (76%), L. loa (39%), and P. falciparum (33%). These results confirm previous reports indicating that almost all subjects in endemic regions may be carriers of M. perstans mf, whereas the prevalence rate of L. loa mf carriers rarely exceeds 40%.19,39 The absence of L. loa mf in a high proportion of the population (61% in this study) may be due to genetically controlled host resistance40,41 or perhaps limits on exposure.

Wuchereria bancrofti was not detected in any sample. We are not aware of any previous epidemiological assessment of lymphatic filariasis in this region. None of our samples was positive for W. bancrofti DNA. This probably reflects the true absence of this infection, but it may also be related to the timing of the blood draw in that W. bancrofti mf are very low or absent in the peripheral blood during daytime. This being said, given the number of individuals sampled, if W. bancrofti were highly endemic, we would have expected to see a number (albeit few) of positives by PCR even during daytime blood draws.42

To evaluate species prevalence, we specifically targeted mf of L. loa, M. perstans, and W. bancrofti for detection. Despite being more sensitive than the widely used thick blood smear to detect microfilariae, qPCR-based assays are still likely to underestimate the absolute prevalence of the L. loa and M. perstans infections given that some individuals with adult parasites are amicrofilaremic. Nevertheless, our data clearly indicate that this region should be considered to be a hyperendemic zone for L. loa, M. perstans, and P. falciparum.

In agreement with previous reports,43,44 we have shown that multiple infections outnumber single or no infection in the studied region. We have also shown that the intensity of M. perstans mf was a significant predictor of the intensity of L. loa mf load, but that P. falciparum (asexual malaria here) intensity was not, perhaps indicating a coadaptation/coevolution of L. loa and M. perstans to the host environment.

We have shown that the intensity of L. loa mf and the strength of its association with the density of M. perstans mf may vary based on geographical location, which is most likely due to a difference in exposure to the vectors that transmit these infections. Thus, the host exposure level promotes the coexistence of these two species. These results point to a mechanism of competition between L. loa and M. perstans, which can determine the abundance of their microfilariae within a host population.41,43,44 However, we cannot exclude an effect of HIV infection on that association. Indeed, a recent study has reported a higher prevalence of L. loa mf in HIV patients in Gabon,45 though no comparison was made between HIV-positive and HIV-negative subjects in terms of L. loa mf in this study. Although this particular association (HIV status and mf number) would be interesting to study, we were not able to individualize L. loa mf counts and HIV status. However, the global prevalence of the studied population ranged up to 7% (E. Delaporte and others, unpublished data), slightly higher than the national prevalence rate in Cameroon, 5.5%.

Interestingly, the fact that few (0.6%) individuals harbor the overwhelming majority (69.7%) of L. loa mf suggests that if one had the ability to target these few people with safe and effective drugs, a significant reduction in community microfilarial load could be achieved such that transmission could not be sustained.23,43 In addition, those highly parasitized L. loa microfilaremic individuals are those at high risk for the development post-ivermectin serious adverse events.23,24

In summary, molecular epidemiologic assessments using tools applicable to previously collected but well-characterized material can provide very important insights into heretofore unexplored coinfections among disparate microorganisms. Such insights would ultimately benefit global health programs generally and provide support to elimination programs for neglected tropical and other infectious diseases.

Supplementary Material

Supplemental Table.

SD5.pdf (398.7KB, pdf)

ACKNOWLEDGMENTS

We thank all volunteers who participated in this study. We also thank the workers from the “Centre de Recherches sur les Maladies Émergentes et Ré-émergentes (CREMER, IMPM, Yaoundé)” and from the health center in Messok for assistance in the field.

Footnotes

Financial support: The study was funded, in part, by the Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases.

Authors' addresses: Papa M. Drame, Joseph Kubofcik, and Thomas B. Nutman, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, E-mails: dramepm@niaid.nih.gov, jkubofcik@niaid.nih.gov, and tnutman@niaid.nih.gov. Céline Montavon and Sébastien D. Pion, Institut de Recherche pour le Développement, Montpellier, France, and University of Montpellier, Montpellier, France, E-mails: celine.montavon@ird.fr and sebastien.pion@ird.fr. Michael P. Fay, Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, E-mail: mfay@niaid.nih.gov.

References

  • 1.Molyneux DH, Hotez PJ, Fenwick A. “Rapid-impact interventions”: how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 2005;2:e336. doi: 10.1371/journal.pmed.0020336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Griffiths EC, Pedersen AB, Fenton A, Petchey OL. The nature and consequences of coinfection in humans. J Infect. 2011;63:200–206. doi: 10.1016/j.jinf.2011.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Manguin S, Bangs MJ, Pothikasikorn J, Chareonviriyaphap T. Review on global co-transmission of human Plasmodium species and Wuchereria bancrofti by Anopheles mosquitoes. Infect Genet Evol. 2010;10:159–177. doi: 10.1016/j.meegid.2009.11.014. [DOI] [PubMed] [Google Scholar]
  • 4.Mboera LE, Senkoro KP, Rumisha SF, Mayala BK, Shayo EH, Mlozi MR. Plasmodium falciparum and helminth coinfections among schoolchildren in relation to agro-ecosystems in Mvomero District, Tanzania. Acta Trop. 2011;120:95–102. doi: 10.1016/j.actatropica.2011.06.007. [DOI] [PubMed] [Google Scholar]
  • 5.Ratmanov P, Mediannikov O, Raoult D. Vectorborne diseases in west Africa: geographic distribution and geospatial characteristics. Trans R Soc Trop Med Hyg. 2013;107:273–284. doi: 10.1093/trstmh/trt020. [DOI] [PubMed] [Google Scholar]
  • 6.van den Berg H, Kelly-Hope LA, Lindsay SW. Malaria and lymphatic filariasis: the case for integrated vector management. Lancet Infect Dis. 2013;13:89–94. doi: 10.1016/S1473-3099(12)70148-2. [DOI] [PubMed] [Google Scholar]
  • 7.Brooker S, Akhwale W, Pullan R, Estambale B, Clarke SE, Snow RW, Hotez PJ. Epidemiology of Plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am J Trop Med Hyg. 2007;77:88–98. [PMC free article] [PubMed] [Google Scholar]
  • 8.Brooker S, Clements AC, Hotez PJ, Hay SI, Tatem AJ, Bundy DA, Snow RW. The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren. Malar J. 2006;5:99. doi: 10.1186/1475-2875-5-99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mulu A, Kassu A, Legesse M, Erko B, Nigussie D, Shimelis T, Belyhun Y, Moges B, Ota F, Elias D. Helminths and malaria co-infections are associated with elevated serum IgE. Parasit Vectors. 2014;7:240. doi: 10.1186/1756-3305-7-240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ndibazza J, Webb EL, Lule S, Mpairwe H, Akello M, Oduru G, Kizza M, Akurut H, Muhangi L, Magnussen P, Vennervald B, Elliott A. Associations between maternal helminth and malaria infections in pregnancy and clinical malaria in the offspring: a birth cohort in Entebbe, Uganda. J Infect Dis. 2013;208:2007–2016. doi: 10.1093/infdis/jit397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ghosh SK, Yadav RS. Naturally acquired concomitant infections of bancroftian filariasis and human plasmodia in Orissa. Indian J Malariol. 1995;32:32–36. [PubMed] [Google Scholar]
  • 12.Chadee DD, Rawlins SC, Tiwari TS. Short communication: concomitant malaria and filariasis infections in Georgetown, Guyana. Trop Med Int Health. 2003;8:140–143. doi: 10.1046/j.1365-3156.2003.01001.x. [DOI] [PubMed] [Google Scholar]
  • 13.Muturi EJ, Mbogo CM, Mwangangi JM, Ng'ang'a ZW, Kabiru EW, Mwandawiro C, Beier JC. Concomitant infections of Plasmodium falciparum and Wuchereria bancrofti on the Kenyan coast. Filaria J. 2006;5:8. doi: 10.1186/1475-2883-5-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dolo H, Coulibaly YI, Dembele B, Konate S, Coulibaly SY, Doumbia SS, Diallo AA, Soumaoro L, Coulibaly ME, Diakite SA, Guindo A, Fay MP, Metenou S, Nutman TB, Klion AD. Filariasis attenuates anemia and proinflammatory responses associated with clinical malaria: a matched prospective study in children and young adults. PLoS Negl Trop Dis. 2012;6:e1890. doi: 10.1371/journal.pntd.0001890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Dantur Juri MJ, Veggiani Aybar CA, Ortega ES, Galante GB, Zaidenberg MO. Plasmodium vivax and Mansonella ozzardi co-infection in north-western Argentina. Malar J. 2013;12:248. doi: 10.1186/1475-2875-12-248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Fokom-Domgue J, Pion SD, Gounoue R, Akame J, Nguipdop-Djomo P, Twum-Danso NA, Thylefors B, Boussinesq M, Kamgno J. Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events. Am J Trop Med Hyg. 2014;90:335–338. doi: 10.4269/ajtmh.13-0189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hillier SD, Booth M, Muhangi L, Nkurunziza P, Khihembo M, Kakande M, Sewankambo M, Kizindo R, Kizza M, Muwanga M, Elliott AM. Plasmodium falciparum and helminth coinfection in a semi urban population of pregnant women in Uganda. J Infect Dis. 2008;198:920–927. doi: 10.1086/591183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wanji S, Tendongfor N, Esum M, Ndindeng S, Enyong P. Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon. Med Microbiol Immunol. 2003;192:15–21. doi: 10.1007/s00430-002-0154-x. [DOI] [PubMed] [Google Scholar]
  • 19.Noireau F, Carme B, Apembet JD, Gouteux JP. Loa loa and Mansonella perstans filariasis in the Chaillu mountains, Congo: parasitological prevalence. Trans R Soc Trop Med Hyg. 1989;83:529–534. doi: 10.1016/0035-9203(89)90280-0. [DOI] [PubMed] [Google Scholar]
  • 20.Akue JP, Nkoghe D, Padilla C, Moussavou G, Moukana H, Mbou RA, Ollomo B, Leroy EM. Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon. PLoS Negl Trop Dis. 2011;5:e1329. doi: 10.1371/journal.pntd.0001329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Bouyou-Akotet MK, Moussavou Boussougou MN, Ovono-Abessolo F, Owono-Medang M, Kombila M. Influence of Mansonella perstans microfilaraemia on total IgE levels in Gabonese patients co-infected with Loa loa. Acta Trop. 2014;131:11–15. doi: 10.1016/j.actatropica.2013.11.012. [DOI] [PubMed] [Google Scholar]
  • 22.Agbolade M, Akinboye DO. Loa loa and Mansonella perstans infections in Ijebu north, western Nigeria: a parasitological study. Jpn J Infect Dis. 2001;54:108–110. [PubMed] [Google Scholar]
  • 23.Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997;350:18–22. doi: 10.1016/S0140-6736(96)11094-1. [DOI] [PubMed] [Google Scholar]
  • 24.Pion SD, Clarke P, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting? Parasitology. 2006;132:843–854. doi: 10.1017/S003118200600984X. [DOI] [PubMed] [Google Scholar]
  • 25.Uttah E, Ibeh DC. Multiple filarial species microfilaraemia: a comparative study of areas with endemic and sporadic onchocerciasis. J Vector Borne Dis. 2011;48:197–204. [PubMed] [Google Scholar]
  • 26.Lello J, Boag B, Fenton A, Stevenson IR, Hudson PJ. Competition and mutualism among the gut helminths of a mammalian host. Nature. 2004;428:840–844. doi: 10.1038/nature02490. [DOI] [PubMed] [Google Scholar]
  • 27.Graham AL, Cattadori IM, Lloyd-Smith JO, Ferrari MJ, Bjørnstad ON. Transmission consequences of coinfection: cytokines writ large? Trends Parasitol. 2007;23:284–291. doi: 10.1016/j.pt.2007.04.005. [DOI] [PubMed] [Google Scholar]
  • 28.Nacher M. Malaria vaccine trials in a wormy world. Trends Parasitol. 2001;17:563–565. doi: 10.1016/s1471-4922(01)02117-1. [DOI] [PubMed] [Google Scholar]
  • 29.Chippaux JP, Boussinesq M, Gardon J, Gardon-Wendel N, Ernould JC. Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitol Today. 1996;12:448–450. doi: 10.1016/0169-4758(96)40006-0. [DOI] [PubMed] [Google Scholar]
  • 30.Metenou S, Babu S, Nutman TB. Impact of filarial infections on coincident intracellular pathogens: Mycobacterium tuberculosis and Plasmodium falciparum. Curr Opin HIV AIDS. 2012;7:231–238. doi: 10.1097/COH.0b013e3283522c3d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ravindran B, Sahoo PK, Dash AP. Lymphatic filariasis and malaria: concomitant parasitism in Orissa, India. Trans R Soc Trop Med Hyg. 1998;92:21–23. doi: 10.1016/s0035-9203(98)90937-3. [DOI] [PubMed] [Google Scholar]
  • 32.Hide G, Tait A. The molecular epidemiology of parasites. Experientia. 1991;47:128–142. doi: 10.1007/BF01945413. [DOI] [PubMed] [Google Scholar]
  • 33.Lymbery AJ, Thompson RC. The molecular epidemiology of parasite infections: tools and applications. Mol Biochem Parasitol. 2012;181:102–116. doi: 10.1016/j.molbiopara.2011.10.006. [DOI] [PubMed] [Google Scholar]
  • 34.Drame PM, Fink DL, Kamgno J, Herrick JA, Nutman TB. Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection. J Clin Microbiol. 2014;52:2071–2077. doi: 10.1128/JCM.00525-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Fink DL, Kamgno J, Nutman TB. Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis. 2011;5:e1299. doi: 10.1371/journal.pntd.0001299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Keiser PB, Coulibaly Y, Kubofcik J, Diallo AA, Klion AD, Traoré SF, Nutman TB. Molecular identification of Wolbachia from the filarial nematode Mansonella perstans. Mol Biochem Parasitol. 2008;160:123–128. doi: 10.1016/j.molbiopara.2008.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Perandin F, Manca N, Calderaro A, Piccolo G, Galati L, Ricci L, Medici MC, Arcangeletti MC, Snounou G, Dettori G, Chezzi C. Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis. J Clin Microbiol. 2004;42:1214–1219. doi: 10.1128/JCM.42.3.1214-1219.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Zeileis A, Kleiber C, Jackman S. Regression models for count data in R. J Stat Softw. 2008;27:1–25. [Google Scholar]
  • 39.Takougang I, Meli J, Lamlenn S, Tatah PN, Ntep M. Loiasis—a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon. Ann Trop Med Parasitol. 2007;101:151–160. doi: 10.1179/136485907X154511. [DOI] [PubMed] [Google Scholar]
  • 40.Garcia A, Abel L, Cot M, Richard P, Ranque S, Feingold J, Demenais F, Boussinesq M, Chippaux JP. Genetic epidemiology of host predisposition microfilaraemia in human loiasis. Trop Med Int Health. 1999;4:565–574. doi: 10.1046/j.1365-3156.1999.00442.x. [DOI] [PubMed] [Google Scholar]
  • 41.Van Hoegaerden M, Chabaud B, Akue JP, Ivanoff B. Filariasis due to Loa loa and Mansonella perstans: distribution in the region of Okondja, Haut-Ogooue Province, Gabon, with parasitological and serological follow-up over one year. Trans R Soc Trop Med Hyg. 1987;81:441–446. doi: 10.1016/0035-9203(87)90163-5. [DOI] [PubMed] [Google Scholar]
  • 42.Gemperli A, Vounatsou P, Sogoba N, Smith T. Malaria mapping using transmission models: application to survey data from Mali. Am J Epidemiol. 2006;163:289–297. doi: 10.1093/aje/kwj026. [DOI] [PubMed] [Google Scholar]
  • 43.Petney TN, Andrews RH. Multiparasite communities in animals and humans: frequency, structure and pathogenic significance. Int J Parasitol. 1998;28:377–393. doi: 10.1016/s0020-7519(97)00189-6. [DOI] [PubMed] [Google Scholar]
  • 44.Raso G, Luginbühl A, Adjoua CA, Tian-Bi NT, Silué KD, Matthys B, Vounatsou P, Wang Y, Dumas ME, Holmes E, Singer BH, Tanner M, N'Goran EK, Utzinger J. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire. Int J Epidemiol. 2004;33:1092–1102. doi: 10.1093/ije/dyh241. [DOI] [PubMed] [Google Scholar]
  • 45.Janssen S, Hermans S, Knap M, Moekotte A, Rossatanga EG, Adegnika AA, Bélard S, Hänscheid T, Grobusch MP. Impact of anti-retroviral treatment and cotrimoxazole prophylaxis on helminth infections in HIV-infected patients in Lambaréné, Gabon. PLoS Negl Trop Dis. 2015;9:e0003769. doi: 10.1371/journal.pntd.0003769. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Table.

SD5.pdf (398.7KB, pdf)

Articles from The American Journal of Tropical Medicine and Hygiene are provided here courtesy of The American Society of Tropical Medicine and Hygiene

RESOURCES